Elevance Health, Inc.
- Stock
- Ticker ELV
- ISIN US0367521038
- NYSE
Performance, volatility and drawdowns of Elevance Health, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $32,956. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −50.4% in 08/2025, measured from the peak in 09/2024. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 45,442 | 48,891 | 49,776 | 50,711 | 49,747 | 50,181 | 50,474 | 51,429 |
| Gross profit | 39,430 | 43,908 | 44,483 | 45,331 | 44,225 | 44,718 | 44,982 | 45,789 |
| Operating income | 673 | 3,170 | 2,425 | 1,295 | 309 | 2,086 | 1,763 | 1,269 |
| EBITDA | 1,379 | 3,543 | 2,805 | 1,682 | 715 | 2,440 | 2,129 | 1,632 |
| Net income | 418 | 2,183 | 1,743 | 1,189 | 547 | 1,764 | 1,463 | 1,365 |
| Earnings per share | 1.87 | 9.61 | 7.72 | 5.32 | 2.54 | 8.00 | 6.71 | 6.27 |
| Balance sheet | ||||||||
| Total assets | 116,889 | 119,717 | 121,938 | 122,749 | 121,494 | 125,827 | 126,438 | 127,801 |
| Liabilities | 75,463 | 77,097 | 78,087 | 78,667 | 77,468 | 81,785 | 81,416 | 83,007 |
| Equity | 41,315 | 42,503 | 43,722 | 43,953 | 43,882 | 43,902 | 44,883 | 44,681 |
| Cash | 8,288 | 7,500 | 8,560 | 8,713 | 9,491 | 9,657 | 10,232 | 10,348 |
| Long-term debt | 29,218 | 28,110 | 28,178 | 31,173 | 30,797 | 30,768 | 30,669 | 30,382 |
| Cash flow | ||||||||
| Operating cash flow | 706 | 1,017 | 2,054 | 1,135 | 84 | 4,332 | 1,913 | 1,267 |
| Capital expenditure | -322 | -196 | -267 | -360 | -293 | -235 | -287 | -267 |
| Free cash flow | 384 | 821 | 1,787 | 775 | -209 | 4,097 | 1,626 | 1,000 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2017 at +58.7%, weakest 2024 at −20.7%. 6 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 21 Oct 2026 | $6.27 |
| 15 Jul 2026 | $6.71 |
| 22 Apr 2026 | $8.00 |
| 6 Feb 2026 | $2.54 |
| 21 Oct 2025 | $5.32 |
| 17 Jul 2025 | $7.72 |
| 22 Apr 2025 | $9.61 |
| 20 Feb 2025 | $1.87 |
| 17 Oct 2024 | $4.36 |
| 17 Jul 2024 | $9.85 |
| 18 Apr 2024 | $9.59 |
| 21 Feb 2024 | $3.66 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €77bn
- Market cap in trading currency
- $85.2bn
- Enterprise value
- $80.3bn
- P/E
- 16.8
- P/S
- 0.42
- P/B
- 1.91
- EV/Sales
- 0.40
- EV/EBITDA
- 11.6
- Earnings yield
- 6.0%
- FCF yield
- 7.6%
Results (last four quarters)
- Revenue
- $202bn
- Gross profit
- $180bn
- EBITDA
- $6.92bn
- Net income
- $5.14bn
- Earnings per share
- $23.52
- Revenue per share
- $934.16
- Revenue growth
- +1.4%
- Earnings growth
- +14.8%
Profitability
- Gross margin
- 89.0%
- Operating margin
- 2.7%
- Net margin
- 2.5%
- Return on equity
- 11.6%
- Return on assets
- 4.0%
Balance sheet and cash flow
- Cash
- $35.7bn
- Cash per share
- $165.21
- Financial debt
- $30.8bn
- Debt/equity %
- 69
- Current ratio
- 1.47
- Book value per share
- $206.80
- Operating cash flow
- $7.60bn
- Free cash flow
- $6.51bn
Dividend
- Dividend yield
- 1.74%
- Dividend (12 months)
- $6.87
- Yield (12 months)
- 1.74%
- Payout ratio
- 29%
- Ex-dividend date
- 10 Sep 2026
Shares and trading
- Shares outstanding
- 216m
- Volume
- 2.03m
- Avg. volume 3 months
- 1.22m
- Relative volume
- 1.6
Price and technicals
- Price
- $394.48
- 1 day
- +1.1%
- 52-week high
- $446.28
- 52-week low
- $280.74
- Distance to 52-week high
- −11.6%
- Distance to 52-week low
- +40.5%
- Distance to 50-day line
- −5.1%
- Distance to 200-day line
- +4.5%
- RSI (14)
- 39
- Volatility 1M
- 42.3%
Performance
- 1 week
- −8.2%
- 1 month
- −11.4%
- 3 months
- −2.0%
- 6 months
- −0.1%
- YTD
- +12.5%
- 1 year
- +24.7%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has ELV performed since 11/2016?
$10,000 grew to $32,956 by 20 Nov 2026, which is +12.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is ELV?
Volatility was 27.8% per year, measured on monthly returns. The largest decline from a peak was −50.4%, with the low in 08/2025.
How does ELV compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, ELV returned +12.7% at 27.8%. The correlation of monthly returns was 0.46; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.